Literature DB >> 1332601

Biological activities of recombinant murine interferons alpha 1 and alpha 4: large difference in antiproliferative effect.

N Swaminathan1, C M Lai, M W Beilharz, S J Boyer, S P Klinken.   

Abstract

The mature forms of two recombinant murine interferons alpha, alpha 1 and alpha 4, have been expressed in vitro using an established transcription and translation system. The relative specific antiviral activity, antiproliferative activity and the natural killer cell stimulating activity of both subtypes were compared in vitro. While the antiviral and natural killer cell stimulating activities of the 2 subtypes were similar, the relative antiproliferative activities varied markedly. On the basis of equal molar inputs, MuIFN-alpha 1 had less than 8% of the antiproliferative activity of MuIFN-alpha 4. This data shows that a large functional difference exists between these two subtypes which are known to be expressed at different levels in mouse L-cells in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332601     DOI: 10.1016/0166-3542(92)90074-f

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  6 in total

1.  Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Soo Cheol Jeong; Hiroshi Aikata; Yoshio Katamura; Takahiro Azakami; Tomokazu Kawaoka; Hiromi Saneto; Kiminori Uka; Nami Mori; Shintaro Takaki; Hideaki Kodama; Koji Waki; Michio Imamura; Hiroo Shirakawa; Yoshiiku Kawakami; Shoichi Takahashi; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

2.  Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis.

Authors:  Vanessa S Cull; Emmalene J Bartlett; Cassandra M James
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

3.  IFN-alpha expression and antiviral effects are subtype and cell type specific in the cardiac response to viral infection.

Authors:  Lianna Li; Barbara Sherry
Journal:  Virology       Date:  2009-11-06       Impact factor: 3.616

4.  Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication.

Authors:  Peter Härle; Vanessa Cull; Martin-Paul Agbaga; Robert Silverman; Bryan R G Williams; Cassandra James; Daniel J J Carr
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

5.  Influence of previous interferon therapy on recurrence after resection of hepatitis c virus-related hepatocellular carcinoma.

Authors:  S Kubo; S Nishiguchi; K Hirohashi; H Tanaka; T Tsukamoto; T Shuto; S Takemura; T Yamamoto; T Ikebe; K Wakasa; S Shiomi; H Kinoshita
Journal:  Jpn J Cancer Res       Date:  2001-01

6.  IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies.

Authors:  Katherine M Audsley; Teagan Wagner; Clara Ta; Hannah V Newnes; Anthony C Buzzai; Samantha A Barnes; Ben Wylie; Jesse Armitage; Tsuneyasu Kaisho; Anthony Bosco; Alison McDonnell; Mark Cruickshank; Vanessa S Fear; Bree Foley; Jason Waithman
Journal:  Front Immunol       Date:  2021-09-06       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.